Report Highlights
The global market for 3D and 4D ultrasound devices should grow from $2.8 billion in 2020 to $3.5 billion by 2025, at compound annual growth rate (CAGR) of 4.1% for the period of 2020-2025.
Report Includes
- 35 data tables and 26 additional tables
- An overview of the global 3D and 4D ultrasound devices market
- Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through 2025
- Detailed description of the 3D and 4D ultrasound devices, their manufacturing process, ultrasound imaging technology, value chain process and pricing analysis
- Analysis of current and future market dynamics and identification of key drivers, restraints and opportunities
- Discussion on potential markets of stationary and portable 3D and 4D ultrasound devices and evaluation of current market trends, market size and market forecast
- Details about R&D, product design and early design prototyping; regulatory submissions and approvals; and legislative requirements for 3D and 4D ultrasound device manufacturing
- Impact analysis of coronavirus on the global economy; government expenditures on COVID-19 and discussion on impact of COVID-19 on supply chain and production of medical devices, insurance providers and overall medical devices industry
- Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Analogic Corp., Canon Medical Systems Corp., FujiFilm Holdings Corp., Hitachi Medical Corp., and Samsung Medison Co. Ltd.
Report Scope
This report offers a detailed picture of the market for 3D and 4D ultrasound devices. It highlights the current and future market potential for 3D and 4D ultrasound devices and provides a detailed analysis of the competitive environment, the regulatory scenario, drivers, restraints, opportunities and trends in the market. This report also covers market projections through 2025 and market shares for key market players.
This report details market shares for 3D and 4D ultrasound devices based on type and geography. Based on type, the market is segmented into stationary 3D and 4D ultrasound devices and portable 3D and 4D ultrasound device segments.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2020-2025. Estimated values are based on 3D and 4D ultrasound device manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
- Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
- Induced Pluripotent Stem Cells: Global Markets (BIO135F)
- Commercial Amino Acids (BIO007N)
- Technical Textiles: Global Markets (CHM136C)
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Endoscopy Devices: Applications and Global Markets
The global market for endoscopy devices is estimated to increase from $51.7 billion in 2022 to reach $75.9 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
4D Imaging in Healthcare
The global market for 4D imaging in healthcare is estimated to grow from $8.1 billion in 2022 to $16.7 billion in 2027, with a compound annual growth rate (CAGR) of 15.3% for the period of 2022-2027.
Recent Reports
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More